vs

Side-by-side financial comparison of NU SKIN ENTERPRISES, INC. (NUS) and Xometry, Inc. (XMTR). Click either name above to swap in a different company.

NU SKIN ENTERPRISES, INC. is the larger business by last-quarter revenue ($320.6M vs $192.4M, roughly 1.7× Xometry, Inc.). NU SKIN ENTERPRISES, INC. runs the higher net margin — 0.6% vs -4.5%, a 5.1% gap on every dollar of revenue. On growth, Xometry, Inc. posted the faster year-over-year revenue change (29.5% vs -12.0%). Over the past eight quarters, Xometry, Inc.'s revenue compounded faster (25.2% CAGR vs -14.5%).

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

Xometry is an online marketplace for sourcing on-demand manufactured parts for prototyping and large-scale production.

NUS vs XMTR — Head-to-Head

Bigger by revenue
NUS
NUS
1.7× larger
NUS
$320.6M
$192.4M
XMTR
Growing faster (revenue YoY)
XMTR
XMTR
+41.6% gap
XMTR
29.5%
-12.0%
NUS
Higher net margin
NUS
NUS
5.1% more per $
NUS
0.6%
-4.5%
XMTR
Faster 2-yr revenue CAGR
XMTR
XMTR
Annualised
XMTR
25.2%
-14.5%
NUS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NUS
NUS
XMTR
XMTR
Revenue
$320.6M
$192.4M
Net Profit
$1.8M
$-8.6M
Gross Margin
66.9%
39.1%
Operating Margin
34.4%
-4.6%
Net Margin
0.6%
-4.5%
Revenue YoY
-12.0%
29.5%
Net Profit YoY
12.7%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUS
NUS
XMTR
XMTR
Q1 26
$320.6M
Q4 25
$370.3M
$192.4M
Q3 25
$364.2M
$180.7M
Q2 25
$386.1M
$162.5M
Q1 25
$364.5M
$151.0M
Q4 24
$445.6M
$148.5M
Q3 24
$430.1M
$141.7M
Q2 24
$439.1M
$132.6M
Net Profit
NUS
NUS
XMTR
XMTR
Q1 26
$1.8M
Q4 25
$14.5M
$-8.6M
Q3 25
$17.1M
$-11.6M
Q2 25
$21.1M
$-26.4M
Q1 25
$107.5M
$-15.1M
Q4 24
$-36.1M
$-9.9M
Q3 24
$8.3M
$-10.2M
Q2 24
$-118.3M
$-13.7M
Gross Margin
NUS
NUS
XMTR
XMTR
Q1 26
66.9%
Q4 25
70.7%
39.1%
Q3 25
70.5%
39.9%
Q2 25
68.8%
40.1%
Q1 25
67.8%
37.3%
Q4 24
62.7%
39.7%
Q3 24
70.1%
39.4%
Q2 24
70.0%
39.9%
Operating Margin
NUS
NUS
XMTR
XMTR
Q1 26
34.4%
Q4 25
6.3%
-4.6%
Q3 25
5.9%
-6.1%
Q2 25
8.0%
-6.3%
Q1 25
-2.7%
-10.2%
Q4 24
-11.9%
-7.8%
Q3 24
4.2%
-8.1%
Q2 24
-28.6%
-11.5%
Net Margin
NUS
NUS
XMTR
XMTR
Q1 26
0.6%
Q4 25
3.9%
-4.5%
Q3 25
4.7%
-6.4%
Q2 25
5.5%
-16.3%
Q1 25
29.5%
-10.0%
Q4 24
-8.1%
-6.7%
Q3 24
1.9%
-7.2%
Q2 24
-26.9%
-10.3%
EPS (diluted)
NUS
NUS
XMTR
XMTR
Q1 26
$0.04
Q4 25
$0.27
Q3 25
$0.34
Q2 25
$0.43
Q1 25
$2.14
Q4 24
$-0.73
Q3 24
$0.17
Q2 24
$-2.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUS
NUS
XMTR
XMTR
Cash + ST InvestmentsLiquidity on hand
$198.7M
$219.1M
Total DebtLower is stronger
$223.6M
Stockholders' EquityBook value
$794.1M
$275.6M
Total Assets
$1.4B
$703.7M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUS
NUS
XMTR
XMTR
Q1 26
$198.7M
Q4 25
$239.8M
$219.1M
Q3 25
$253.0M
$224.5M
Q2 25
$265.4M
$225.8M
Q1 25
$213.6M
$231.4M
Q4 24
$198.0M
$239.8M
Q3 24
$237.8M
$234.0M
Q2 24
$232.9M
$240.9M
Total Debt
NUS
NUS
XMTR
XMTR
Q1 26
$223.6M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
NUS
NUS
XMTR
XMTR
Q1 26
$794.1M
Q4 25
$805.2M
$275.6M
Q3 25
$799.8M
$272.0M
Q2 25
$787.8M
$270.4M
Q1 25
$754.0M
$309.9M
Q4 24
$651.5M
$314.5M
Q3 24
$706.9M
$315.2M
Q2 24
$686.2M
$315.8M
Total Assets
NUS
NUS
XMTR
XMTR
Q1 26
$1.4B
Q4 25
$1.4B
$703.7M
Q3 25
$1.4B
$698.9M
Q2 25
$1.4B
$687.0M
Q1 25
$1.4B
$690.1M
Q4 24
$1.5B
$680.1M
Q3 24
$1.6B
$678.2M
Q2 24
$1.6B
$678.6M
Debt / Equity
NUS
NUS
XMTR
XMTR
Q1 26
0.28×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUS
NUS
XMTR
XMTR
Operating Cash FlowLast quarter
$4.4M
Free Cash FlowOCF − Capex
$-5.9M
FCF MarginFCF / Revenue
-3.0%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUS
NUS
XMTR
XMTR
Q1 26
Q4 25
$16.6M
$4.4M
Q3 25
$27.5M
$5.8M
Q2 25
$35.8M
$-427.0K
Q1 25
$389.0K
$-3.7M
Q4 24
$25.8M
$9.1M
Q3 24
$31.4M
$-3.6M
Q2 24
$51.2M
$-9.1M
Free Cash Flow
NUS
NUS
XMTR
XMTR
Q1 26
Q4 25
$5.9M
$-5.9M
Q3 25
$17.6M
$-1.7M
Q2 25
$35.8M
$-7.4M
Q1 25
$-13.2M
$-9.2M
Q4 24
$13.2M
$4.5M
Q3 24
$22.8M
$-8.4M
Q2 24
$43.1M
$-13.5M
FCF Margin
NUS
NUS
XMTR
XMTR
Q1 26
Q4 25
1.6%
-3.0%
Q3 25
4.8%
-0.9%
Q2 25
9.3%
-4.5%
Q1 25
-3.6%
-6.1%
Q4 24
3.0%
3.1%
Q3 24
5.3%
-6.0%
Q2 24
9.8%
-10.2%
Capex Intensity
NUS
NUS
XMTR
XMTR
Q1 26
Q4 25
2.9%
5.3%
Q3 25
2.7%
4.1%
Q2 25
0.0%
4.3%
Q1 25
3.7%
3.6%
Q4 24
2.8%
3.1%
Q3 24
2.0%
3.4%
Q2 24
1.9%
3.3%
Cash Conversion
NUS
NUS
XMTR
XMTR
Q1 26
Q4 25
1.15×
Q3 25
1.61×
Q2 25
1.69×
Q1 25
0.00×
Q4 24
Q3 24
3.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUS
NUS

Segment breakdown not available.

XMTR
XMTR

US$159.1M83%
Non Us$33.3M17%

Related Comparisons